In connection with the above November 2025 Offering, on November 18, 2025, the Company entered into a placement agency agreement with Maxim Group LLC (the “Placement Agent”)
Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to na…
a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to national and global deployment. Our commercialization approach may include either a…
- option expense related to the stock option cancellation agreements stated above. During the three and nine months ended December 31, 2024 , the Company recorded stock-based compensation - option ex…
Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to na…
a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to national and global deployment. Our commercialization approach may include either a…
Autonomix Medical, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
AMIX-DEBT-7725
Warrants outstanding: 0.01
90%
xbrl warrant detail from xbrl 2025-03-31.
AMIX-DEBT-7726
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-03-31.
Autonomix Medical, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Autonomix Medical, Inc..
Autonomix Medical, Inc. Ownership
Holder
Name
Confidence
Evidence
AMIX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC
GEODE CAPITAL MANAGEMENT, LLC
90%
13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 15 tracked holders.
Autonomix Medical, Inc. Extended Supply Chain Network